Functional characterization of SMARCA4 variants identified by targeted exome-sequencing of 131,668 cancer patients
SMARCA4 is the core catalytic subunit of the mammalian SWI/SNF complex and is known to be mutated in many cancers. Here, the authors detect more than 10,000 SMARCA4 variants across different cancer subtypes and find hotspot mutations throughout the helicase domain, which reduce remodeling activity.
Enregistré dans:
Auteurs principaux: | Tharu M. Fernando, Robert Piskol, Russell Bainer, Ethan S. Sokol, Sally E. Trabucco, Qing Zhang, Huong Trinh, Sophia Maund, Marc Kschonsak, Subhra Chaudhuri, Zora Modrusan, Thomas Januario, Robert L. Yauch |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2020
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/660128134d924fbaad6dcc27af8cef1f |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Acta Nº668
par: Banco Central de Chile
Publié: (2019) -
Resolution 668(XXXIV) Statistical Conference of the Americas of the Economic Commission for Latin America and the Caribbean
Publié: (2014) -
Acta No. 131
par: Banco Central de Chile
Publié: (2019) -
Clinical impact of EZH2 and its antagonist SMARCA4 in ovarian cancer
par: Katharina Leitner, et autres
Publié: (2020) -
BET inhibitor suppresses migration of human hepatocellular carcinoma by inhibiting SMARCA4
par: Hae In Choi, et autres
Publié: (2021)